NCT06220760

Brief Summary

Using of Ultra sound in assessment of Placenta Accreta Index to predict the surgical outcomes of Placenta accreta

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
27 days until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

10 months

First QC Date

January 14, 2024

Last Update Submit

November 18, 2025

Conditions

Placenta PreviaPlacenta Accreta

Outcome Measures

Primary Outcomes (1)

  • to decide If placenta accreta index (PAI) can predict suitable type of operation needed whether Conservative management/fertility-sparing techniques or Caesarean hysterectomy

    23 months

Secondary Outcomes (3)

  • Incidence of fetal complication associated with placenta accreta

    23 months

  • Incidence of maternal complications associated with placenta accreta

    23 months

  • The need for ICU admission after placenta accreta surgery and its duration

    23 months

Interventions

UltrasoundDIAGNOSTIC_TEST

The use of US to calculate placenta accreta index

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with Previous Scar of cesarean section who are 32weeks of gestation or more who are known to be Placenta previa

You may qualify if:

  • pregnant women with gestational age 32 weeks or more
  • singleton pregnancy
  • known to have placenta previa (lower edge of the placenta within 5 cm from internal Os )
  • with at least previous 1 cesarean section

You may not qualify if:

  • the patient is active in labor
  • haemodynamically unstable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Asyut Governorate, 71515, Egypt

Location

Related Links

MeSH Terms

Conditions

Placenta PreviaPlacenta Accreta

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mohammed Nagy, MD

    Assiut University

    STUDY CHAIR

  • Mansour Khalifa, MD

    Assiut University

    STUDY DIRECTOR

  • Mostafa Hussien, MD

    Assiut University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

January 14, 2024

First Posted

January 24, 2024

Study Start

February 20, 2024

Primary Completion

December 30, 2024

Study Completion

September 30, 2025

Last Updated

November 21, 2025

Record last verified: 2025-11

Locations

EG(1)